Ross Hauser, MD, Danielle Matias, PA-C, Demi Foster, APRN
Prolotherapy, as practiced in our office, involves multiple injections of a dextrose-based solution to the various ligament and tendon attachments around the shoulder, as well as inside the joint. Prolotherapy to all of the adjacent structures stimulates a natural inflammatory response in the weakened rotator cuff tissues. This mild, localized inflammatory reaction draws immune cells to the area to regenerate the injured tissues. The increase in blood flow and regenerative cells is the body’s natural healing response. The body also responds by depositing collagen at the site of injury, strengthening the rotator cuff tendons that once were weak.
Rotator cuff pain can make everyday movements difficult: reaching into a cupboard, dressing, lifting something away from the body, or sleeping on the affected shoulder. An ultrasound or MRI may describe tendinosis, a partial tear, bursitis, or several findings together. The next question is what those findings mean for treatment.
At Caring Medical, our discussion of shoulder pain includes the rotator cuff and the supporting structures around the joint. A painful tendon may be only one part of the problem. However, neither a tendon abnormality nor persistent pain establishes that every surrounding ligament is injured.
Rotator cuff tendinopathy and a rotator cuff tear are different problems
The rotator cuff consists of four muscles and their tendons. They help lift and rotate the arm and keep the upper arm bone centered in the shoulder socket. The supraspinatus tendon, frequently discussed in injection studies, assists with lifting the arm and contributes to shoulder stability.
Tendinopathy describes a painful tendon disorder. Tendinosis commonly describes degenerative changes within the tendon. A partial-thickness tear affects part of its thickness; a full-thickness tear extends through it. The size of the tear, tendon retraction, muscle condition, and whether the injury is recent can all influence treatment decisions.
These distinctions matter when reading a study. A trial involving chronic supraspinatus tendinopathy cannot automatically answer whether an injection can restore a large, retracted tear. Likewise, improvement in pain does not necessarily mean that tendon continuity or strength has been restored.
Other shoulder problems can coexist with cuff symptoms: subacromial bursitis, biceps tendon disease, acromioclavicular joint pain, arthritis, frozen shoulder, or labral pathology. Pain originating in the neck can also resemble shoulder pain. Our broader article on rotator cuff tendinopathy and treatment options explores these treatment comparisons further.
What does Prolotherapy aim to do?
Dextrose Prolotherapy uses a concentrated sugar solution injected into selected tissues. Proposed mechanisms include local cellular signaling and a tissue-repair response. The clinical question is whether that response produces meaningful, lasting improvements in pain, function, and tissue integrity.
These outcomes should be assessed separately. A lower pain score, better ability to reach overhead, and a change in ultrasound appearance are different findings. None alone proves that a tear has closed or that the tendon has regained normal mechanical strength.
The published studies also use different targets. Some inject near an enthesis, the attachment of a tendon or ligament to bone; others target the tendon itself or other shoulder structures. Concentration, volume, number of sessions, and accompanying rehabilitation vary. Results from one protocol should not be presented as proof of every treatment described as Prolotherapy.
Why supporting ligaments and the joint capsule enter the discussion
The capsule and ligaments help constrain shoulder motion, while muscles and tendons provide dynamic control. Our clinical perspective considers whether painful instability or another supporting-tissue problem accompanies the cuff disorder. This is a possible contributor in selected patients, not a universal explanation for rotator cuff disease.
Our discussion of comprehensive shoulder treatment covers the glenohumeral joint, acromioclavicular joint, posterior capsule, ligament attachments, and cuff tendon attachments. These are distinct anatomical targets. An illustration or treatment demonstration cannot determine which structure is responsible for another person’s pain.

The illustration identifies anatomical treatment sites; it does not establish that every site should be injected or that a tear will heal.
Our shoulder impingement article discusses the relationship between cuff symptoms and other shoulder structures. The term “impingement” does not establish ligament injury or identify a single treatment appropriate for everyone.
What do the studies show?
A useful reading of the evidence includes positive findings, comparisons that found no difference, and benefits that did not persist. Older studies remain relevant because they help explain why newer reviews can reach different conclusions.
Prolotherapy compared with exercise for chronic rotator cuff lesions
A randomized comparative trial published in 2017 enrolled 120 patients with symptoms lasting more than six months; 101 completed the study. Both groups performed home exercises. One group also received ultrasound-guided Prolotherapy, while the comparison group received a supervised physiotherapy program. Both improved. Among completers, 92.9% in the Prolotherapy group and 56.8% in the comparison group reported good or excellent outcomes. (1)
These were clinical outcomes, not proof of anatomical tear repair. Losses to follow-up and differences in the treatment programs matter when interpreting the comparison. The findings support further investigation rather than a promise that the same percentage of all patients will respond.
Single-injection trials for supraspinatus tendinopathy
A placebo-controlled trial published in 2019 evaluated 31 patients with chronic supraspinatus tendinopathy. An ultrasound-guided dextrose injection at the tendon attachment improved pain, disability, and some movement measures compared with saline at two weeks. The benefit was not sustained at six weeks, and tendon imaging did not show a corresponding morphological improvement. (2)
A separate randomized, double-blind trial published in 2022 included 57 patients receiving dextrose or saline injections. The dextrose group improved from baseline in pain and disability at two weeks, but those effects were not sustained at six weeks. Some movement and ultrasound measures changed later. (3)
The important distinction is that improvement from a patient’s own baseline is not necessarily evidence of superiority to the comparison treatment. These trials also do not demonstrate that simply adding more injections would have maintained the early response; that question requires a study designed to test it.
One Prolotherapy treatment versus one cortisone injection
A 2021 clinical trial analyzed 33 patients with rotator cuff-related shoulder pain. One group received ultrasound-guided dextrose into the supraspinatus tendon; the other received corticosteroid into the subacromial bursa. Both improved in pain and disability at three and twelve weeks, with no significant difference between groups. (4)
This preserves an important finding from the original article: Prolotherapy was not superior in that particular comparison. The study also used different anatomical injection targets, so it was not simply a comparison of two substances delivered into identical tissues.
A small study reporting similar symptom outcomes cannot establish equal effectiveness in every patient or prove that either treatment is free of complications.
Repeated injections and the distinction between pain relief and regeneration
A randomized trial published in 2016 included 73 patients with painful rotator cuff tendinopathy. Participants received three monthly treatments with dextrose at painful tendon attachments, saline at those attachments, or saline above them. All also received physical therapy. At nine months, 59% in the dextrose group maintained the study’s specified pain improvement, compared with 37% in the attachment-saline group and 27% in the superficial-saline group. The difference was significant against superficial saline, but not against attachment saline. Ultrasound outcomes did not differ between groups. (5)
This study offers evidence for symptom benefit in some patients, while directly limiting a regeneration claim. The results did not show that the pain differences arose from structural tendon repair. Rehabilitation was part of the treatment in all groups.
New 2026 research: a three-way injection trial
A prospective multicenter randomized trial assigned 45 patients with shoulder tendinopathy to ultrasound-guided oxygen–ozone, corticosteroid, or Prolotherapy injections, with 15 patients per group. All groups improved. Corticosteroid produced the lowest pain scores at two weeks; Prolotherapy produced the lowest scores at two and six months. (6)
This suggests that the timing of symptom relief may differ among treatments. However, the small groups, six-month follow-up, and absence of a placebo or rehabilitation-only comparison limit the conclusions. The results do not establish effectiveness for all tear patterns, demonstrate restored tendon strength, or establish a universally best injection.
Oxygen–ozone was a research comparator. Its inclusion here does not describe a treatment offered by Caring Medical.
New 2026 systematic review: overall benefit remains uncertain
A 2026 systematic review included 12 randomized trials of dextrose Prolotherapy for chronic shoulder pain; seven contributed to each pooled analysis. Neither overall pain nor functional improvement was statistically superior to control treatments. An exploratory subgroup suggested better pain outcomes with at least three sessions, but this was not a direct randomized comparison of single versus repeated treatment. Findings varied substantially across studies. (7)
The review searched through January 20, 2025. Its publication year should not be taken to mean that it incorporated the newly published 2026 three-way trial. It also concerned chronic shoulder pain across different diagnoses, which limits its specificity to rotator cuff tendinopathy.
For patients, this means that favorable individual trials need to be considered alongside uncertainty in the pooled evidence.
Why have systematic reviews reached different conclusions?
The 2025 review of rotator cuff disorders
A 2025 systematic review identified 13 studies involving 936 patients. Its analysis reported improvements in pain and disability with Prolotherapy, while calling for additional trials, more standardized protocols, and longer follow-up. No major adverse effects were reported in the included evidence, but that does not establish that rare complications cannot occur. (8)
This positive review and the less favorable 2026 review should both remain in the article. They examined different evidence sets and used different inclusion and analysis decisions. Counting the number of positive publications is not a substitute for assessing the quality and applicability of the underlying trials.
Comparing corticosteroid, hyaluronic acid, PRP, and Prolotherapy
A 2025 network meta-analysis included 29 randomized trials and 1,800 patients. Prolotherapy ranked favorably for pain outcomes, while hyaluronic acid and Prolotherapy ranked favorably for several functional outcomes. PRP also ranked favorably for longer-term pain relief. (9)
A network analysis combines direct and indirect comparisons. A high ranking does not necessarily mean a clinically important advantage over every other treatment. Differences in patient selection, injection targets, and outcome timing can affect those rankings.
A 2019 network meta-analysis of 18 studies similarly suggested a shorter-term role for corticosteroid and possible longer-term benefits from Prolotherapy or PRP, while specifically cautioning about heterogeneity—differences among studies. (10)
These findings support examining the time course of outcomes. They do not justify claiming that combining PRP with Prolotherapy is superior merely because the treatments performed favorably in separate comparisons.
Earlier review: injection technique was inconsistent
A systematic review published in 2020 included five trials with 272 participants. Some multisite attachment-injection protocols performed better than rehabilitation comparisons, while ultrasound-guided supraspinatus trials did not show significant advantages over certain injection controls. Follow-up ranged from six weeks to twelve months. (11)
This helps explain why “Does Prolotherapy work?” is too broad a question. The relevant diagnosis, injection target, comparison treatment, and desired outcome all matter. Protocol differences are a reason for uncertainty, not proof that an unfavorable trial used the wrong treatment.
Does needing more than one injection prove that Prolotherapy works?
No. A series of treatments is different from several needle placements during one visit, and neither should be confused with several anatomical targets. These distinctions are important when interpreting reports of repeated treatment.
A short-lived response after one injection may prompt questions about dose or treatment schedule. It does not prove that additional sessions will produce durable recovery. Similarly, an exploratory subgroup favoring repeated sessions cannot determine the best number of treatments for an individual.
The published evidence does not establish a universal three-to-six-treatment requirement, a reliable dose–response relationship, or a guaranteed cumulative benefit. A more conclusive study would compare defined schedules in similar patients receiving otherwise comparable care.
Caring Medical’s published shoulder research
Chronic shoulder pain
Our retrospective study analyzed 94 shoulders from 90 people with longstanding shoulder pain. Patients reported improvements in pain and other aspects of daily function after dextrose Prolotherapy. The study used questionnaires and had no untreated or sham-treated comparison group. It did not isolate rotator cuff pathology as the explanation for every patient’s symptoms. (12)
These observations help explain our interest in treating painful shoulder structures. They do not establish how much improvement was attributable to the injections or show that rotator cuff tears healed anatomically.
Glenoid labrum lesions
A separate clinic-authored case series involved 33 patients with glenoid labral lesions. Patient-reported symptoms and activity improved at a mean follow-up of sixteen months. It was a noncontrolled questionnaire study. (13)
The labrum is the fibrocartilage rim around the shoulder socket; it is not the rotator cuff. This research belongs in the broader discussion of shoulder symptoms and instability, but it cannot serve as a rotator cuff repair trial. More information is available in our glenoid labrum research summary.
Videos and treatment illustrations: what they can show
In the following video, Danielle Matias discusses ultrasound images from a patient treated with PRP Prolotherapy for a supraspinatus tear.
A patient example can illustrate a clinical discussion. It cannot establish the expected result for another person or show that the combined treatment performs better than rehabilitation, either injection alone, or surgery.
Our video discussion of Prolotherapy for shoulder pain and arthritis and the shoulder treatment illustration help explain anatomical targets and differences among shoulder problems. A demonstration describes a particular treatment; it is not a prescription for every painful shoulder.
Pain after surgery is not always a persistent cuff problem
Persistent postoperative pain may reflect stiffness, a recurrent tear, arthritis, nerve-related pain, or another condition. A structure that appears healed on imaging does not explain every ongoing symptom. Conversely, persistent pain does not prove that a nerve is trapped.
The shoulder pain and arthritis video discussion includes hydrodissection, an injection technique intended to separate a nerve from adjacent tissues in selected nerve-related conditions. That is a separate treatment concept from dextrose Prolotherapy for cuff tendinopathy. The rotator cuff trials summarized here do not establish its effectiveness for unexplained postoperative shoulder pain.
Rehabilitation and surgery
A 2025 clinical practice guideline supports active rehabilitation as an initial treatment for rotator cuff tendinopathy. Exercise aims to improve pain, strength, movement, and functional capacity. The guideline covers tendinopathy and selected related conditions; its recommendations should not be assumed to resolve every full-thickness tear. (14)
Pain relief from an injection may be useful, but the ability to perform daily tasks and tolerate progressive loading remains important. Returning to heavy lifting solely because pain has decreased can overlook persisting weakness or an important structural injury.
Surgical assessment may be particularly important after an acute traumatic tear with substantial weakness, inability to lift the arm, or a large or retracted tear. Chronic tear decisions depend on more than the MRI label, including symptoms, function, muscle condition, and the likelihood of successful repair. An injection should not be presented as an equivalent substitute for a repairable tendon rupture without supporting evidence.
Summary
We view Prolotherapy research as a developing body of evidence rather than a guarantee. Selected trials support pain and functional improvement, but systematic reviews remain inconsistent, protocols differ, and structural tendon repair has not been reliably established by the findings presented here.
The useful questions are specific: Which condition was studied? What was injected and where? What comparison was used? Did improvement last? Was the outcome pain relief, function, imaging, or all three?
Those distinctions allow patients to understand promising results without confusing symptom improvement with proven healing of a rotator cuff tear.
This article provides general educational information and does not replace an individual medical evaluation or diagnosis.
Published research papers from our doctors at Caring Medical on Shoulder Disorders
- Prolotherapy: A Non-Invasive Approach to Lesions of the Glenoid Labrum; A Non-Controlled Questionnaire Based Study
- This paper was published in The Open Rehabilitation Journal.
- Hauser RA, Dolan E, Orlofsky A. Prolotherapy: a non-invasive approach to lesions of the glenoid labrum; a non-controlled questionnaire-based study. The Open Rehabilitation Journal. 2013 Dec 27;6(1).[Google Scholar]
- A Retrospective Study on Hackett-Hemwall Dextrose Prolotherapy for Chronic Shoulder Pain at an Outpatient Charity Clinic in Rural Illinois
- This paper was published in the Journal of Prolotherapy.
- Hauser RA, Hauser MA. A retrospective study on Hackett-Hemwall dextrose Prolotherapy for chronic shoulder pain at an outpatient charity clinic in rural Illinois. J Prolotherapy. 2009;4:205-16. [Google Scholar]
Related articles
Prolotherapy injections for the treatment of shoulder impingement syndrome
References
1 Seven MM, Ersen O, Akpancar S, Ozkan H, Turkkan S, Yıldız Y, Koca K. Effectiveness of prolotherapy in the treatment of chronic rotator cuff lesions. Orthopaedics & Traumatology: Surgery & Research. 2017;103(3):427-433. doi:10.1016/j.otsr.2017.01.003. [Google Scholar]
2 Lin CL, Huang CC, Huang SW. Effects of hypertonic dextrose injection in chronic supraspinatus tendinopathy of the shoulder: a randomized placebo-controlled trial. European Journal of Physical and Rehabilitation Medicine. 2019;55(4):480-487. doi:10.23736/s1973-9087.18.05379-0. [Google Scholar]
3 Lin CL, Chen YW, Wu CW, Liou TH, Huang SW. Effect of Hypertonic Dextrose Injection on Pain and Shoulder Disability in Patients with Chronic Supraspinatus Tendinosis: A Randomized Double-Blind Controlled Study. Archives of Physical Medicine and Rehabilitation. 2022;103(2):237-244. doi:10.1016/j.apmr.2021.07.812. [Google Scholar]
4 Nasiri A, Mohamadi Jahromi LS, Vafaei MA, Parvin R, Fakheri MS, Sadeghi S. Comparison of the Effectiveness of Ultrasound-Guided Prolotherapy in Supraspinatus Tendon with Ultrasound-Guided Corticosteroid Injection of Subacromial Subdeltoid Bursa in Rotator Cuff-Related Shoulder Pain: A Clinical Trial Study. Advanced Biomedical Research. 2021;10:12. doi:10.4103/abr.abr_181_20. [Google Scholar]
5 Bertrand H, Reeves KD, Bennett CJ, Bicknell S, Cheng AL. Dextrose Prolotherapy Versus Control Injections in Painful Rotator Cuff Tendinopathy. Archives of Physical Medicine and Rehabilitation. 2016;97(1):17-25. doi:10.1016/j.apmr.2015.08.412. [Google Scholar]
6 Babaei-Ghazani A, Yousefi N, Forogh B, Janbazi L, Ahadi T, Soleymanzadeh H, Jahanjoo F, Fadavi HR, Rouzegari F. Comparing Ultrasound-Guided Injection of Oxygen-Ozone vs. Corticosteroid vs. Prolotherapy in the Treatment of Shoulder Tendinopathy: A Prospective, Multicenter Randomized Clinical Trial. Pain Research and Management. 2026;2026(1):e1582085. doi:10.1155/prm/1582085. [Google Scholar]
7 Darmawan R, Waluyo Y, Sam N, Zainal ATF, Makkaraka MAG, Go R. The effect of dextrose prolotherapy on pain and functional outcomes in chronic shoulder pain: A systematic review and meta-analysis of randomized controlled trials. Qatar Medical Journal. 2026;2026(3):62. doi:10.5339/qmj.2026.62. [Google Scholar]
8 Sony S, Kantha M, Shekhar S, Kumar A, Bhandari B, Muthuramalingam KP. Exploring dextrose prolotherapy in rotator cuff disorders: A systematic review and meta-analysis. Indian Journal of Anaesthesia. 2025;69(9):881-898. doi:10.4103/ija.ija_566_25. [Google Scholar]
9 Wu M, Yan C, Xu Y, Yan Z. The evolving efficacy landscape of intra-articular injections for rotator cuff injuries over time: a network meta-analysis of randomized controlled studies. Journal of Orthopaedic Surgery and Research. 2025;20(1):1038. doi:10.1186/s13018-025-06475-8. [Google Scholar]
10 Lin MT, Chiang CF, Wu CH, Huang YT, Tu YK, Wang TG. Comparative Effectiveness of Injection Therapies in Rotator Cuff Tendinopathy: A Systematic Review, Pairwise and Network Meta-analysis of Randomized Controlled Trials. Archives of Physical Medicine and Rehabilitation. 2019;100(2):336-349.e15. doi:10.1016/j.apmr.2018.06.028. [Google Scholar]
11 Catapano M, Zhang K, Mittal N, Sangha H, Onishi K, de Sa D. Effectiveness of Dextrose Prolotherapy for Rotator Cuff Tendinopathy: A Systematic Review. PM&R. 2020;12(3):288-300. doi:10.1002/pmrj.12268. [Google Scholar]
12 Hauser RA, Hauser MA. A Retrospective Study on Hackett-Hemwall Dextrose Prolotherapy for Chronic Shoulder Pain at an Outpatient Charity Clinic in Rural Illinois. Journal of Prolotherapy. 2009;1(4):205–216. [Google Scholar]
13 Hauser RA, Dolan E, Orlofsky A. Prolotherapy: A Non-Invasive Approach to Lesions of the Glenoid Labrum; A Non-Controlled Questionnaire Based Study. The Open Rehabilitation Journal. 2013;6:69–76. doi:10.2174/1874943701306010069. [Google Scholar]
14 Desmeules F, Roy JS, Lafrance S, Charron M, Dubé MO, Dupuis F, Beneciuk JM, Grimes J, Kim HM, Lamontagne M, McCreesh K, Shanley E, Vukobrat T, Michener LA. Rotator Cuff Tendinopathy Diagnosis, Nonsurgical Medical Care, and Rehabilitation: A Clinical Practice Guideline Journal of Orthopaedic & Sports Physical Therapy. 2025;55(4):235-274. doi:10.2519/jospt.2025.13182. [Google Scholar]